Clinical Trial

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 9, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To investigates the effects of combined pharmacotherapy with solifenacin and mirabegron versus solifenacin with vaginal estrogen cream in women with detrusor overactivity.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-12-26; most recent amendment 2025-05-06.
Trial Details
NCT Number NCT06197295
Lead Sponsor Mackay Memorial Hospital
Conditions Urinary Bladder, Overactive, Effect of Drug
Enrollment 200 participants
Start Date 2022-06-16
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-09